Azalea Therapeutics is a series a startup. 1 investor tracked.
Azalea Therapeutics is a startup founded in 2025 based in the United States. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Azalea Therapeutics is a biotechnology company focused on redefining precision genomic medicines by engineering therapeutic cells directly inside patients. The company utilizes its proprietary Enveloped Delivery Vehicle (EDV) technology to achieve precise, site-specific genome editing within T cells, eliminating the need for complex ex vivo manufacturing and harsh pre-treatments like lymphodepletion.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.